Javascript must be enabled to continue!
Magnesium, calcium, zinc, and nitrogen loss in trauma patients during continuous renal replacement therapy
View through CrossRef
BACKGROUND: Whether standard nutrition support is sufficient to compensate for mineral loss during continuous renal replacement therapy (CRRT) is not known. METHODS: Adult men with traumatic injuries were recruited; one‐half of recruits required CRRT for acute renal failure. All urine and effluent (from CRRT) were collected for 72 hours. Urine, effluent, and dialysate were analyzed for magnesium, calcium, and zinc using atomic absorption spectrometry. Urea nitrogen in blood, urine, and effluent were determined by measuring conductivity changes after the addition of urease. Blood was analyzed for magnesium and calcium as part of routine care. Intake was calculated from orders and intake records. RESULTS: Patients receiving CRRT (n = 6) lost 23.9+/‐3.1 mmol/d (mean +/‐ SEM) of magnesium and 69.8+/‐2.7 mmol/d of calcium compared with 10.2+/‐1.2 mmol/d and 2.9+/‐2.5 mmol/d, respectively, lost in patients not in acute renal failure (n = 6; p <.01). Zinc intake was significantly greater than loss in both groups (p <.03). Urea nitrogen excretion did not differ between groups. Serum magnesium was 0.75+/‐0.04 mmol/L for CRRT patients, significantly lower than the 0.90+/‐0.03 mmol/L for control patients (p <.01). Total blood calcium was below normal in both groups; ionized calcium was below normal in CRRT patients. CONCLUSIONS: CRRT caused significant loss of magnesium and calcium, necessitating administration of more magnesium and calcium than was provided in standard parenteral nutrition formulas. However, additional zinc was not required. CRRT removed amounts of urea nitrogen similar to amounts removed by normally functioning kidneys.
Title: Magnesium, calcium, zinc, and nitrogen loss in trauma patients during continuous renal replacement therapy
Description:
BACKGROUND: Whether standard nutrition support is sufficient to compensate for mineral loss during continuous renal replacement therapy (CRRT) is not known.
METHODS: Adult men with traumatic injuries were recruited; one‐half of recruits required CRRT for acute renal failure.
All urine and effluent (from CRRT) were collected for 72 hours.
Urine, effluent, and dialysate were analyzed for magnesium, calcium, and zinc using atomic absorption spectrometry.
Urea nitrogen in blood, urine, and effluent were determined by measuring conductivity changes after the addition of urease.
Blood was analyzed for magnesium and calcium as part of routine care.
Intake was calculated from orders and intake records.
RESULTS: Patients receiving CRRT (n = 6) lost 23.
9+/‐3.
1 mmol/d (mean +/‐ SEM) of magnesium and 69.
8+/‐2.
7 mmol/d of calcium compared with 10.
2+/‐1.
2 mmol/d and 2.
9+/‐2.
5 mmol/d, respectively, lost in patients not in acute renal failure (n = 6; p <.
01).
Zinc intake was significantly greater than loss in both groups (p <.
03).
Urea nitrogen excretion did not differ between groups.
Serum magnesium was 0.
75+/‐0.
04 mmol/L for CRRT patients, significantly lower than the 0.
90+/‐0.
03 mmol/L for control patients (p <.
01).
Total blood calcium was below normal in both groups; ionized calcium was below normal in CRRT patients.
CONCLUSIONS: CRRT caused significant loss of magnesium and calcium, necessitating administration of more magnesium and calcium than was provided in standard parenteral nutrition formulas.
However, additional zinc was not required.
CRRT removed amounts of urea nitrogen similar to amounts removed by normally functioning kidneys.
Related Results
MO451: The Usefulness of Calcium/Magnesium Ratio in the Risk Stratification of Early Onset of Renal Replacement Therapy
MO451: The Usefulness of Calcium/Magnesium Ratio in the Risk Stratification of Early Onset of Renal Replacement Therapy
Abstract
BACKGROUND AND AIMS
Recently, a growing number of studies have reported a close relationship between high serum calcium...
British Food Journal Volume 45 Issue 9 1943
British Food Journal Volume 45 Issue 9 1943
I now pass on to an aspect of calcium metabolism which is more topical, but probably more controversial. I refer to the incidence of calcium deficiency. By what means can we determ...
FAKTOR-FAKTOR YANG MEMPENGARUHI MORTALITAS PADA PASIEN DENGAN FRAKTUR COSTA: Literature Review
FAKTOR-FAKTOR YANG MEMPENGARUHI MORTALITAS PADA PASIEN DENGAN FRAKTUR COSTA: Literature Review
FAKTOR-FAKTOR YANG MEMPENGARUHI MORTALITAS PADA PASIEN DENGAN FRAKTUR COSTA: Literature Review Anna Tri Wahyuni1), Masfuri2), Liya Arista3)1,2,3 Fakultas Ilmu Keperawatan Univers...
#1250 Measurement of ionized calcium with a point-of-care ionometer during treatment with etelcalcetide
#1250 Measurement of ionized calcium with a point-of-care ionometer during treatment with etelcalcetide
Abstract
Background and Aims
Etelcalcetide is an intravenous calcimimetic indicated for the treatment of mineral and bone disord...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
What is the Proper Composition of the Dialysate Magnesium and How Much Magnesium is Removed During Pre-Dilution Online Hemodiafiltration?
What is the Proper Composition of the Dialysate Magnesium and How Much Magnesium is Removed During Pre-Dilution Online Hemodiafiltration?
Aim: The aim of the study was to determine the ideal dialysate magnesium during hemodialysis, knowing that the
solution used is not satisfactory and is often associated with low se...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
7987 Ravenous Bone
7987 Ravenous Bone
Abstract
Disclosure: Y. Oo: None. L. Srisawitri: None. P. Patel: None. M. Thein: None.
Introduction Hungry bone syndrome ( HBS ) is the rapid drop in ...

